mortality/aging
• delayed the onset and in particular the progression of disease
• increase the survival by about 30 days to a maximal life span of 175 d
|
muscle
• decreased muscle fiber diameter at 123 d and 150 d, compared with Tg(Myl1-Igf1)1Nros mice
• attenuated muscle atrophy, compared with Tg(SOD1*G93A)1Gur mice
|
• at all stages of disease, including at paralysis stage (123 d)
|
• altered fiber type composition at 138 d with a shift toward a fast fiber type
|
nervous system
astrocytosis
(
J:95812
)
• decrease in astroglial activation at paralysis stage (123 d) in the spinal cord, compared with Tg(SOD1*G93A)1Gur mice
|
• motor neuron loss is less severe at 112 and 123 d, compared with Tg(SOD1*G93A)1Gur mice
|